TCL Archive Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program September 5, 1975
TCL Archive NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer August 26, 2005
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm January 2, 1987